Jacqueline Gerena | Director, Risk Management Strategy
Johnson & Johnson

Jacqueline Gerena is a pharmaceutical leader with expertise in risk management, regulatory compliance, and cross-functional leadership. She currently serves as the Director of Risk Management Strategy at Johnson & Johnson, leading a team at the forefront of developing innovative approaches for executing single and shared Risk Evaluation and Mitigation Strategies (REMS) programs across multiple therapeutic areas.  Throughout her career at leading pharmaceutical companies like Alexion Pharmaceuticals and Aimmune Therapeutics, Jacqueline has been instrumental in developing and managing U.S. and global risk management programs. Her experience spans various therapeutic areas and first-in-class products, demonstrating her commitment to advancing healthcare solutions through the translation of regulatory and safety requirements into effective, scalable programs that ensure safe access to critical treatments. Beyond her professional work, Jacqueline is actively engaged in board service and advisory council roles across multiple organizations, including Pathways-Senderos, a community-based organization focused on youth development and education. She is a strong advocate for women's empowerment, health equity, and the growth of emerging leaders. Her leadership is recognized for its thoughtfulness, mentorship, integrity, and sustained commitment to creating meaningful impact across industry, community, and service.